Arlington Heights, IL, Aug. 08, 2017 -- The American Society of Plastic Surgeons (ASPS) is proud to welcome Sientra, a leading medical aesthetics company, as a Platinum Level sponsor of Plastic Surgery The Meeting, which takes place October 6 – 10 in Orlando. The premier educational and networking event for board-certified plastic surgeons across the world, Plastic Surgery The Meeting is attended by more than 3,000 plastic surgeons, trainees and other allied health professionals interested in translating the continuing medical education and information they receive into their practices to improve patient care and outcomes.
|
|||
"Sientra has a long-standing commitment to patient safety, product quality and technological innovation,” said Debra Johnson, MD, president of the American Society of Plastic Surgeons. “We value their commitment to working exclusively with board-certified plastic surgeons and appreciate their continued support of the patient safety and enhanced quality-of-life outcomes we advance at Plastic Surgery The Meeting.”
Corporate partners at the Premier Support levels receive unprecedented opportunities to communicate with aesthetic and reconstructive plastic surgeons from around the world. The Platinum Level of support is intended for companies who want to stand apart from their competitors by demonstrating the highest level of commitment to the education of plastic surgeons and advancement of the specialty.
“We are excited to continue our long-standing partnership with ASPS, a society that shares our commitment to the specialty of board-certified plastic surgeons,” said Sientra Chairman and Chief Executive Officer, Jeff Nugent. “As we continue to build a diversified global aesthetics company, we appreciate the opportunities the partnership affords us and is increasingly important in building relationships with key aesthetic and reconstructive plastic surgeons.”
For more information, visit our Plastic Surgery The Meeting website.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.
For more information about Sientra, visit www.sientra.com
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0db87659-6991-4653-87a7-8fbf4b9ea857
Adam Ross American Society of Plastic Surgeons 773-332-4719 [email protected]


LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
OpenAI Explores Massive Funding Round at $750 Billion Valuation
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 



